Wells Fargo & Company Valneva Se Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Valneva Se stock. As of the latest transaction made, Wells Fargo & Company holds 215,907 shares of VALN stock, worth $943,513. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215,907
Previous 183,110
17.91%
Holding current value
$943,513
Previous $1.28 Million
1.64%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VALN
# of Institutions
11Shares Held
718KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$1.55 Million0.15% of portfolio
-
Alpha Centric Advisors LLC San Juan, PR118KShares$515,6600.6% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$109,3460.08% of portfolio
-
Morgan Stanley New York, NY3.56KShares$15,5390.0% of portfolio
-
Ridgewood Investments LLC550Shares$2,4030.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $302M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...